44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pharmacology and Medicinal Chemistry

Sign up for email alert when new content gets added: Sign up

Can amoxicillin clavulanate be used for treating MRSA?

Author(s): Sana Jamil, Uzma Saad and Saleem Hafiz*

Objective: To determine the frequency of beta lactamase producing Staphlococcus aureus and their sensitivity to Amoxicillin clavulanate in major cities of Pakistan. Setting: Various laboratories of the country with one as the central Laboratory. Materials and Methods: Seven hundred and ninety two consecutive clinical isolates of Staphylococcus aureus were collected from 8 laboratories all over Pakistan i.e. Karachi, Peshawar, Lahore, Sukkhur, Islamabad, Quetta, and Mirpur, Azad Kashmir. Antibiotic sensitivity was done by Kirby Bauer disc diffusion method and Beta lactamase production was identified by using Nitrocefin test. Results: Forty two percent of the isolates were found to be Methicillin resistant Staphylococcus aureus (MRSA) out of which 87.9% were positive for Beta lactamase production 52.1% of these Beta lactamase producing MRSA were sensitive to amoxicillin-clavulanate and the remaining (47.9%) were resistant. Conclusion: If beta lactamase producing Staphlococcus aureus are tested against beta-lactam antimicrobial agents in combination with clavulanic acid or sulbactam (Beta-lactamase inhibitors), they become susceptible to the Beta-lactam antimicrobial agents. This might have therapeutic and epidemiological implications in near future.


Full-Text | PDF
 
Google Scholar citation report
Citations : 19

Journal of Pharmacology and Medicinal Chemistry received 19 citations as per Google Scholar report

pulsus-health-tech
Top